Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

by Monica Gerson, Benzinga Staff Writer

February 26, 2014 4:18 AM | 29 seconds read | Make a Comment

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio. Gilead Sciences

GILD

has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion. Celgene

CELG

has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%. Alexion Pharmaceuticals

ALXN

has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27. Biogen Idec

BIIB

has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted In: Trading Ideas Biotechnology Industry Large-Cap PEG ratio

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.